4
Changes in Ownership
Vaxcyte, Inc. Filed Acc 0001230724-26-000012
PRESIDENT AND CFO sold 10,000 shares at an average $57.28 ($572,837)
- PRESIDENT AND CFO acquired 10,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
GUGGENHIME ANDREW · PRESIDENT AND CFO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-07-06 | Exercise or conversion : show line 1 in the form 10b5-1 | +10,000 | $5.35 | $53,500 | 114,395 | D |
| 2026-07-06 | Sale : show line 2 in the form 10b5-1 | −7,913 | $57.16 | $452,283 | 106,482 | D |
| 2026-07-06 | Sale : show line 3 in the form 10b5-1 | −2,087 | $57.76 | $120,553 | 104,395 | D |
| Open-market sales · 10,000 sh · avg $57.28 · $572,837 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-07-06 | Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (right to buy) | −10,000 | 226,827 | D |
Loading xslF345X06/wk-form4_1783380710.xml…